A Deconsolution for disinfections of emerging pathogenic organisms such as the Influenza A & B, B), Methicillin Resistant Staphylococcus aureus, Vancomycin Resistant Enterococcus faecalis, Enterobactor aerogenes and E. Coli O157:H7 and ESBL. Also proven effective against Staphylococcus aureus, Salmonella choleraesuis, Klebsiella pheumoniae and Trichtophyton entagrophytes. Unlike other disinfectants, this product has been proven effective in the presence of 5% serum contamination and is an invaluable tool in controlling the vectors of transmission in hospitals, nursing homes and schools.

Product Description Highly efficacious and environmentally safe, Jymrsa' High Level Disinfection Products are produced exclusively by Modec, Inc. and compounded specifically for the decontamination and mitigation of high level pathogenic organisms that are often found in medical and other settings.

Technology The US Government developed the underlying technology at Sandia National Laboratories and patented the Formulation pursuant to US Patent 6,566,574 B1. Jymrsa's Disinfection products are commercially manufactured by Modec pursuant to its license 00-C00872 with Sandia Corp.

Yahoo News/Sixty Minutes Coverage - Super Bugs

Sandia Influenza Inactivation Study and Comparison Data (pdf)

Sandia Test Study against Bovine Corona Virus (SARS)

Marketed and Distributed Exclusively by (Click on Logo):

Modec, Inc., 4725 Oakland Street, Denver, Colorado USA 80239 1-800-967-7887 - 303-373-2696